Amarin Corporation Probability Of Bankruptcy


Probability Of Bankruptcy Analysis

For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis. The score is used to predict probability of a firm or a fund experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Amarin Corporation 
Probability Of Bankruptcy 
53 %

Distress Driver Correlations

About Probability Of Bankruptcy

Probability of Bankruptcy SHOULD NOT be confused with actual chance of a company to file for chapter 7, 11, 12 or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty to meet its current financial obligations towards its creditors or to deliver on the expectations of its investors. Macroaxis derives these conditions on a daily bases from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns including short term and long term historical volatility. Other factors taken into account include analysis of liquidity, revenues patterns, RND expenses, as well as public headlines and social sentiment.
Compare Amarin Corporation to competition

Amarin Corporation Probability Of Bankruptcy Assessment

  Of Bankruptcy 
Benchmark  Embed   Amarin Corporation Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 53%. This is 16.64% higher than that of the Healthcare sector, and 14.42% lower than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 23.11% lower than the firm.

Filter other Stocks by Probability Of Bankruptcy

Probability Of Bankruptcy Input Range 
Click to run this filter
Filter Other Equities
Found 10 equities by Probability Of Bankruptcy
NVO NYQNovo Nordisk AS
1 %
TEVA NYQTeva Pharmaceutical Industries Limited
25 %
RDY NYQDr Reddys Laboratories Ltd
1 %
TARO NYQTaro Pharmaceutical Industries Ltd
1 %
UTHR NMSUnited Therapeutics Corporation
1 %
ENDP NMSEndo International plc
39 %
DEPO NMSDepomed Inc
45 %
AMPH NMSAmphastar Pharmaceuticals Inc
3 %
SCLN NMSSciClone Pharmaceuticals Inc
2 %
SCMP NGMSucampo Pharmaceuticals Inc
38 %
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  

Chance of Financial Distress

Amarin Corporation plc has more than 53 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Return On Asset(32.02) %
Profit Margin(124.61) %
Operating Margin(103.19) %
Current Valuation584.45 M
Shares Outstanding184.44 M
Shares Owned by Insiders10.16 %
Shares Owned by Institutions29.30 %
Number of Shares Shorted16.21 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales4.62 times
Revenue91.37 M
Gross Profit53.88 M
EBITDA(93.46 M)
Net Income(146.84 M)
Cash and Equivalents81.36 M
Cash per Share0.44 times
Total Debt243.45 M
Current Ratio2.32 times
Book Value Per Share(0.98) times
Cash Flow from Operations(96.92 M)
Short Ratio11.52 times
One Year High2.59
One Year Low1.24
Earnings Per Share(0.81) times
Price to Earnings To Growth(0.02) times
Number of Employees210
Market Capitalization429.75 M
Total Asset152.71 M
Retained Earnings(1.15 B)
Working Capital70.84 M
Current Asset124.43 M
Current Liabilities53.59 M
Z Score-9.2